HRTX CIK: 818033

Heron Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
40.3
FY22:
52.8
FY23:
61.9
FY24:
106
FY25:
114
(positive)
Change from FY21 to FY25
millions USD
FY21:
−218
FY22:
−120
FY23:
−45.5
FY24:
27.1
FY25:
38.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−215
FY22:
−177
FY23:
−104
FY24:
−5.06
FY25:
3.06
(positive)
Change from FY21 to FY25
millions USD
FY21:
−221
FY22:
−182
FY23:
−111
FY24:
−13.6
FY25:
−20.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−221
FY22:
−182
FY23:
−111
FY24:
−13.6
FY25:
−20.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data